Funded Research

The MRF has funded millions of dollars in melanoma research since 1998.

The Melanoma Research Foundation is proud to award research grants supporting the study of melanoma prevention, diagnosis and treatment across the spectrum of the disease, including cutaneous, ocular and mucosal melanoma. These include the following:

  • Team Awards (established in 2014) - Two-year awards, up to 0,000 per year
  • Established (Senior) Investigator Awards (established in 2006) - Two-year awards, up to 0,000 per year
  • Career Development (Junior) Awards (established in 1998) - Two-year awards, up to ,000 per year
  • Medical Student Awards (established in 2011) - One-year awards, up to ,000
  • Society for Melanoma Research Young Investigator Awards (sponsored by the MRF since 2013) - One-year awards, ,000 per year
  • Society for Melanoma Research Christopher J. Marshall Award (sponsored by the MRF since 2015) - One-year awards, ,000 per year

View a summary of the 2019 Research Recipients here.

An integrative genomics approach to identify metabolic drivers of melanoma

Career Development Award 2013
Principal Investigator: Dr. Narendra Wajapeyee
Institution:


Role of HDAC6 in the modulation of immune-related pathways in melanoma

Career Development Award 2013
Principal Investigator: Dr. Alejandro Villagra
Institution: H. Lee Moffitt Cancer Center & Research Institute


MYC as an invisible driver in metastatic uveal melanoma

Established Investigator – CURE OM 2013
Principal Investigator: Dr. William Tansey
Institution: Vanderbilt University Medical Center
CURE OM funded


The impact of BRAF oncogenic events on immune gene expression

Career Development Award 2013
Principal Investigator: Brian Pollack, MD, PhD
Institution: Emory University


Monitoring melanoma targeted therapy using microfluidic CTC-Chip

Career Development Award 2013
Principal Investigator: Dr. Xi Luo
Institution: Massachusetts General Hospital Center for Cancer


The BRAF-regulated IncRNA BANCR regulates melanoma cell migration

Career Development Award 2013
Principal Investigator: Dr. Ross Flockhart
Institution: Stanford University


Modulating immunosuppressive signals in cancer cells using FDA-approved compounds

Established Investigator Award 2013
Principal Investigator: Dr. Eduardo Davila
Institution: University of Maryland, Baltimore


Overcoming resistance to MEK inhibition in advanced uveal melanoma

Career Development Award – CURE OM 2013
Principal Investigator: Dr. Richard Carvajal
Institution: Memorial Sloan-Kettering Cancer Center
CURE OM funded


Elucidating the role of BMI1 in metastatic melanoma

Established Investigator Award 2013
Principal Investigator: Dr. Jacqueline Lees
Institution: Massachusetts Institute of Technology


Understanding and targeting ER stress pathways in melanoma

Established Investigator Award 2013
Principal Investigator: Dr. Ze'ev Ronai
Institution: Sanford-Burnham Medical Research Institute